HIV Treatment: ART, PrEP, PEP, and Comprehensive Care
Modern HIV Management
Antiretroviral Therapy (ART)
- Combination of ≥2 drug classes (e.g., 2 NRTIs + an integrase inhibitor).
- Goal: viral suppression (<50 copies/mL) → immune recovery, zero transmission risk (U=U).
- Lifelong, daily adherence is essential.
Prevention
- PrEP (Pre-Exposure Prophylaxis): Daily TDF/FTC or TAF/FTC (or long-acting injectable cabotegravir) for HIV-negative high-risk individuals. >99% effective with adherence.
- PEP (Post-Exposure Prophylaxis): 28-day ART course started ≤72 hours after exposure. High efficacy if started early.
Adjunctive Care
- Prophylaxis/treatment of opportunistic infections (PCP, toxoplasmosis, MAC, fungal).
- Vaccinations (pneumococcal, hepatitis A/B, HPV, COVID).
- Cardiovascular, renal, and bone monitoring.
- Mental health, substance use, and social support services.
Key Message
With ART, HIV is a manageable chronic condition. Regular care = near-normal lifespan.
HIV & AIDS - Related Articles
- HIV vs. AIDS: Understanding the Critical Difference
- Chronic HIV Infection: Treatment, Stages, Prevention & Long-Term Management
- Understanding HIV Symptoms: Timeline & Stages After Infection
- HIV Risk from Blood on Underwear: What You Need to Know
- Overcoming Barriers to Comprehensive HIV/AIDS Care
- Understanding Early HIV Symptoms: What to Watch For
- Why Some Babies Are Born with HIV: Healthcare Access, Stigma, Poverty, and Substance Abuse
